Lv1
40 积分 2024-07-19 加入
Assessment of the Effective Dose to Immune Cells as an Independent Predictor of Durvalumab Response in NSCLC After Chemoradiotherapy: A Multicenter Study
1个月前
已关闭
Endoplasmic reticulum-mitochondrial calcium transport contributes to soft extracellular matrix-triggered mitochondrial dynamics and mitophagy in breast carcinoma cells
3个月前
已完结
癌痛全程管理中国专家共识
4个月前
已完结
Treatment-related lymphopenia impairs the treatment response of anti-PD-1 therapy in esophageal squamous cell carcinoma
4个月前
已完结
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating Nintedanib Versus Placebo as Prophylaxis Against Radiation Pneumonitis in Patients With Unresectable NSCLC Undergoing Chemoradiation Therapy
5个月前
已完结
Safety and Efficacy of HL301 In Radiation Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer Receiving Curative Concurrent Chemoradiotherapy: A Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Phase 2a Clinical Trial
5个月前
已完结
Efficacy of Thymosin α1 in Management of Radiation Pneumonitis in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Concurrent Chemoradiotherapy: A Phase 2 Clinical Trial (GASTO-1043)
5个月前
已完结
Impact of radiation dose to the immune cells in unresectable or stage III non-small cell lung cancer in the durvalumab era
6个月前
已完结
Stereotactic versus Standard Tumor Irradiation in unresectable Locally Advanced NSCLC with Durvalumab Maintenance: A Multicenter Study with propensity score matching
8个月前
已完结
Proton therapy may reduce the risk of cancer progression during immune checkpoint inhibitor therapy: a propensity score-matched analysis of intensity-modulated proton versus photon radiotherapy
8个月前
已完结
皖公网安备34019202002308
